Ahmed Sherif, MD
Gastroenterology · Huntington, WVNPI 1750492096
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (52.8%), travel and lodging and education — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by Olympus Corporation Of The Americas at 35.2% of the total.
Across 221 payments — averaging $46.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Olympus Corporation Of The Americas$4K
- Boston Scientific$2K
- AbbVie$2K
- Olympus America Inc.$565
- Apollo Endosurgery US Inc$364
- Ambu Inc.$236
- plus $2K from 20 others
Across 2 payments — averaging $9100.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bausch Health US, LLC$18K
What the payments were for
- Travel & lodging$4,86247%
- Food & beverage$5,44753%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Olympus Corporation Of The Americas | 32 | $3,630 |
| Boston Scientific | 16 | $2,252 |
| AbbVie | 110 | $1,755 |
| Olympus America Inc. | 13 | $565 |
| Apollo Endosurgery US Inc | 6 | $364 |
| Ambu Inc. | 1 | $236 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $145 |
| Gilead | 4 | $143 |
| Johnson & Johnson(3 entities) | 3 | $129 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $124 |
| Bristol Myers Squibb | 2 | $119 |
| Cook Medical LLC | 1 | $116 |
| Sanofi | 1 | $108 |
| Janssen Scientific Affairs, LLC | 1 | $103 |
| Lilly USA, LLC | 3 | $89 |
| Steris Corporation | 1 | $80 |
| QOL Medical, LLC | 3 | $59 |
| Novo Nordisk | 3 | $58 |
| Pfizer | 3 | $55 |
| E.r. Squibb & Sons, L.L.C. | 1 | $53 |
| Regeneron Healthcare Solutions, Inc. | 1 | $33 |
| Phathom Pharmaceuticals, Inc. | 2 | $29 |
| Nevro Corp. | 1 | $23 |
| Merck | 1 | $20 |
| Endogastric Solutions, Inc | 1 | $20 |
| Biogen | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DISPOSABLE DISTAL ATTACHMENT$3,008
- Olympus$2,703
- Single Use Electrosurgical Knife KD-655$1,889
- GENERAL - BILIARY DEVICES$604
- SPYGLASS$530
- AXIOS$395
- OverStitch Endoscopic Suturing System$143
- ORBERA Intragastric Balloon System$143
- WATCHMAN FLX$131
- Rinvoq$125
- ACQUIRE$122
- Hemospray$116
- DUPIXENT$108
- GATTEX$108
- STELARA$103
- ZEPOSIA$103
- EXALT Model D$101
How this compares
$10,321 in reported general payments places this provider in the 80th percentile of 72 gastroenterology providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 17 | $35,082 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 253 | $4,962 |
| Sucralfate | 29 | $3,976 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 101 | $2,230 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 19 | $1,382 |
| Esomeprazole Magnesium | 16 | $920 |
| Omeprazole | 82 | $806 |
| Pantoprazole Sodium | 44 | $617 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieCreon | $1,755 | $35,08217 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 72 gastroenterology providers in West Virginia.
Other gastroenterology in Huntington
- Wesam FrandahHuntington$28K
- Matthew RohrbachHuntington$7K
- John EastoneHuntington$7K
- Charles HuhHuntington$7K
- Umapathy SundaramHuntington$5K
- Maen KamalHuntington$3K
- Pramod PantangiHuntington$3K
- Helgi SigmundssonHuntington$3K
- Larry CarterHuntington$2K
- Adnan ElghezewiHuntington$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.